Closes in 14 daysOpportunity HT942526TBDRPTDRA

DoW Tick-Borne Disease Therapeutic/Diagnostic Research Award

Defense Health Agency Contracting Activity - DHACA · Department of Defense

At a glance

DoW Tick-Borne Disease Therapeutic/Diagnostic Research Award is an open federal grant opportunity from the Defense Health Agency Contracting Activity - DHACA (Department of Defense). Applications are due October 22, 2026. Total estimated funding is $2.65M across about 2 awards. The notice is unrestricted by applicant type, subject to any clarifications in the notice. Cost sharing is not required. It is funded under Assistance Listing 12.420 (Military Medical Research and Development).

Summary assembled from the official notice's fields. The official notice governs.

Key facts

Posted: May 5, 2026
Close date: Oct 22, 2026
Archive date: Nov 21, 2026
Est. award date: Sep 30, 2027
Award floor: Not specified
Award ceiling: Not specified
Est. total funding: $2,650,000
Expected awards: 2
Cost sharing: Not required
Funding instrument: Grant
Opportunity category: Discretionary

Who can apply

Unrestricted (any entity type)

Based on the published notice. Review the official notice for complete eligibility requirements.

What it funds

Official synopsis as published by the agency, formatted for readability.

Summary: The intent of the fiscal year 2026 (FY26) Tick-Borne Disease Research Program (TBDRP) Therapeutic/Diagnostic Research Award (TDRA) is to support product-driven therapeutic and diagnostic development research aimed at reducing the burden of Lyme disease and/or other tick-borne diseases and conditions, and improving patient care and/or quality of life. Treatment-focused applications should be therapeutic evaluation studies designed to advance new ideas aimed at drug or treatment discovery that are still in the early/preclinical stages of development. Diagnosis-focused applications should propose diagnostic approaches that will be readily integrated into clinical settings.

https://cdmrp.health.mil/pubs/press/2026/tbdrppreann

Assistance Listing

What is an ALN?

12.420Military Medical Research and DevelopmentProgram →

Reported obligations under ALN 12.420

Historical data · not a prediction

FY24

$1.48B

FY25

$1.2B

FY26

— est.

Source: SAM.gov Assistance Listing 12.420. Program-wide totals, not awards from this specific opportunity.

Agency contact (as published)

Ebony S Simmons Grantor
help@eBRAP.org
301-619-2105

Quick answers

When is the deadline for “DoW Tick-Borne Disease Therapeutic/Diagnostic Research Award”?

According to the official notice, applications are due October 22, 2026. Confirm the deadline and submission time on Grants.gov before applying.

Who is eligible to apply for “DoW Tick-Borne Disease Therapeutic/Diagnostic Research Award”?

The notice lists eligibility as unrestricted — open to any type of entity — subject to clarifications in the notice's additional eligibility information.

How much funding is available through “DoW Tick-Borne Disease Therapeutic/Diagnostic Research Award”?

Per the notice, total estimated program funding is $2,650,000 and the agency expects to make about 2 awards.

How do I apply for “DoW Tick-Borne Disease Therapeutic/Diagnostic Research Award”?

Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity HT942526TBDRPTDRA), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.

Matched on shared Assistance Listings, agency, categories and eligible applicant types.

Closes in 6 daysALN 12.420